Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Approval symbols : ABT save search
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published: 2024-04-24 (Crawled : 16:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.04%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.1%
H: 0.0%
C: 0.0%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
rare first opioid approval for
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
fda device approval heart
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa
Published: 2024-03-08 (Crawled : 18:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.98%
H: 3.17%
C: 0.9%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
fda brukinsa approval
FDA Decisions: BeiGene Secures Record Fifth Oncology Approval for Brukinsa; Opdivo Approved for B...
Published: 2024-03-08 (Crawled : 17:00) - biospace.com/
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.98%
H: 3.17%
C: 0.9%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.68%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
fda opdivo approved approval
FDA Decisions: J&J's Bladder Cancer Drug Wins Full Approval
Published: 2024-01-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.71%
H: 0.0%
C: -0.15%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.36%
H: 2.11%
C: 1.29%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 0.6%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.21%
H: 0.0%
C: 0.0%
fda drug approval bladder cancer
FDA Decisions: Casgevy's Surprise Early Approval and Another Nod for Takeda's HyQvia
Published: 2024-01-17 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.76%
H: 0.73%
C: -0.06%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.12%
H: 0.77%
C: 0.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
fda hyqvia approval
FDA Decisions: Casgevy's Surprise Early Approval and Another Nod for Takeda's...
Published: 2024-01-17 (Crawled : 17:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -1.83%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.76%
H: 0.73%
C: -0.06%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.02%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.12%
H: 0.77%
C: 0.27%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.06%
C: -0.5%
fda approval
FDA Decisions: AstraZeneca and Ionis Gain Approval for Self-Administered hATT...
Published: 2023-12-22 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.06%
H: 1.21%
C: 0.99%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
fda approval astrazeneca
FDA Decisions: AstraZeneca and Ionis Gain Approval for Self-Administered hATTR-PN Treatment
Published: 2023-12-22 (Crawled : 14:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 3.66%
H: 0.0%
C: -0.12%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.06%
H: 1.21%
C: 0.99%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: 1.09%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 1.52%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.03%
H: 0.0%
C: 0.0%
fda approval astrazeneca treatment
FDA Decisions: Merck's Gefapixant Whiffs Again while Calliditas' Tarpeyo Wins Full Approval
Published: 2023-12-21 (Crawled : 14:30) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: 0.97%
H: 1.38%
C: 0.71%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -0.08%
H: 0.0%
C: 0.0%
fda tarpeyo approval
FDA Decisions: First Two Sickle Cell Gene Therapies Win Approval
Published: 2023-12-08 (Crawled : 22:00) - biospace.com/
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
PRGO | $31.23 2.43% 0.0% 960K
|
Health Technology
|
| O: -0.13%
H: 1.02%
C: -2.82%
JNJ | News | $148.53 -0.69% -0.14% 9.6M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.88%
H: 0.0%
C: 0.0%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
fda first approval cell
Servier’s Tibsovo Gets FDA Approval as First Targeted Therapy for MDS
Published: 2023-10-25 (Crawled : 12:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.89%
H: 0.09%
C: -1.04%
fda approval therapy
Abbott Receives FDA Approval for World's First Dual-Chamber Leadless Pacemaker
Published: 2023-07-05 (Crawled : 13:00) - prnewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.47%
H: 1.04%
C: 0.61%
fda approval
Abbott Receives FDA Approval for TactiFlex™ Ablation Catheter for Treatment of Abnormal Heart Rhythm
Published: 2023-05-19 (Crawled : 13:00) - prnewswire.com
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: 0.47%
H: 0.92%
C: -0.05%
fda approval treatment heart
Abbott Receives FDA Approval for Its Spinal Cord Stimulation Systems to Treat Chronic Back Pain in People Who Have Limited Surgical Options
Published: 2023-05-16 (Crawled : 17:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.27%
H: 0.84%
C: -0.14%
fda back approval
Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis
Published: 2023-01-17 (Crawled : 16:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.01%
H: 0.69%
C: -0.1%
fda system approval
Abbott Receives FDA Approval for Aveir™ VR Leadless Pacemaker System to Treat Patients with Slow Heart Rhythms
Published: 2022-04-04 (Crawled : 13:20) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -0.6%
H: 0.94%
C: 0.86%
fda system heart approval
Abbott's CardioMEMS™ HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure
Published: 2022-02-21 (Crawled : 15:00) - biospace.com/
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
| Email alert
Add to watchlist
fda heart fda approval cardio approval system
Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™
Published: 2022-02-03 (Crawled : 15:30) - biospace.com/
KNWN | $2.53
|
Manufacturing
|
| O: 0.0%
H: 1.27%
C: 0.63%
ABT | News | $106.89 -0.65% -0.22% 5.1M
|
Health Technology
|
| O: -1.08%
H: 1.79%
C: 1.15%
DXCM | $137.86 2.88% 2.8% 3.2M
|
Health Technology
|
| O: -0.98%
H: 1.55%
C: -2.94%
technology trial approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.